NCT05687721 2025-06-15Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder CancerVA Office of Research and DevelopmentPhase 1/2 Withdrawn
NCT06218667 2024-10-31A Study of Copanlisib in Combination with Degarelix in People with Prostate CancerMemorial Sloan Kettering Cancer CenterPhase 1/2 Withdrawn